Abstract:To explore the role of YAP, a key effector of the Hippo pathway, in temporomandibular joint (TMJ) ankylosis. The temporal and spatial expression of YAP was detected via immunohistochemistry and multiplex immunohistochemistry on postoperative Days 1, 4, 7, 9, 11, 14 and 28 in a sheep model. Isolated mesenchymal stem cells (MSCs) from samples of the Day 14. The relative mRNA expression of YAP was examined before and after the osteogenic induction of MSCs. A YAP-silenced MSC model was constructed, and the effect of YAP knockdown on MSC function was examined. YAP is expressed in the nucleus of the key sites that determine the ankylosis formation, indicating that YAP is activated in a physiological state. The expression of YAP increased gradually over time. Moreover, the number of cells coexpressing of RUNX2 and YAP—with the osteogenic active zone labelled by RUNX2—tended to increase after Day 9. After the osteogenic induction of MSCs, the expression of YAP increased. After silencing YAP, the osteogenic, proliferative and migratory abilities of the MSCs were inhibited. YAP is involved in the early development of TMJ bony ankylosis. Inhibition of YAP using shRNA might be a promising way to prevent or treat TMJ ankylosis.

What problem does this paper attempt to address?

This paper attempts to solve the problem of the molecular mechanism of temporomandibular joint ankylosis (TMJ ankylosis). Specifically, the research focuses on exploring the role of Yes - associated protein (YAP), as a key effector of the Hippo signaling pathway, in the early development of bony ankylosis of the temporomandibular joint. By detecting the expression and activation of YAP in a sheep model at different time points and evaluating the impact of YAP knockdown on the function of mesenchymal stem cells (MSCs) through in vitro experiments, the researchers hope to reveal the specific mechanism of action of YAP in the formation process of TMJ bony ankylosis. ### Research Background Temporomandibular joint ankylosis is a disease caused by bony or fibrous adhesions of the joint structure, mainly manifested as limited mouth opening, and trauma is one of the main causes. At present, the specific molecular mechanism of TMJ ankylosis is still unclear. What is known is that the formation process of TMJ ankylosis is similar to excessive bone healing, and mesenchymal stem cells (MSCs) play a key role in this process. Therefore, inhibiting the osteogenic and chondrogenic differentiation of MSCs may be an effective strategy for the prevention and treatment of TMJ ankylosis. ### Research Methods 1. **Animal Model and Tissue Processing**: - Use 3 - month - old male small - tailed sheep to perform unilateral TMJ surgery to induce bony ankylosis. - Collect tissue samples on the 1st, 4th, 7th, 9th, 11th, 14th, and 28th days after the operation for histological and immunohistochemical analysis. 2. **Immunohistochemistry and Multiplex Immunohistochemistry**: - Detect the expression and distribution of YAP and RUNX2 at different time points. - Use multiplex immunohistochemistry technology to further analyze the expression level of YAP in early bony ankylosis. 3. **Isolation and Culture of MSCs**: - Isolate MSCs from newly formed ankylotic callus and conduct osteogenic induction experiments. - Evaluate the osteogenic ability of MSCs by Alizarin red staining and alkaline phosphatase (ALP) activity detection. 4. **YAP Knockdown Experiment**: - Construct a YAP - knockdown MSCs model and use shRNA technology to knockdown YAP expression. - Evaluate the impact of YAP knockdown on the osteogenic, proliferative, and migratory abilities of MSCs. ### Main Findings - **Expression and Activation of YAP**: - YAP begins to be expressed in the nucleus on the 1st day after the operation, indicating that it has been activated in the acute inflammation stage. - As time goes by, the expression of YAP gradually increases and is significantly expressed in the osteogenic area (marked as RUNX2 - positive). - Starting from the 9th day, the co - expression of YAP and RUNX2 gradually increases, indicating the early participation of YAP in the osteogenic area. - **Impact of YAP Knockdown on MSCs Function**: - After YAP knockdown, the osteogenic ability, proliferative ability, and migratory ability of MSCs are all inhibited. - These results indicate that YAP plays an important role in the early development of TMJ bony ankylosis. ### Conclusion YAP participates in the early development of bony ankylosis of the temporomandibular joint by regulating the function of mesenchymal stem cells. Inhibiting the expression of YAP may be an effective method for preventing or treating TMJ ankylosis.

YAP promotes the early development of temporomandibular joint bony ankylosis by regulating mesenchymal stem cell function

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.

BMSC-Derived Small Extracellular Vesicles Induce Cartilage Reconstruction of Temporomandibular Joint Osteoarthritis Via Autotaxin–YAP Signaling Axis

Inhibition of YAP with siRNA prevents cartilage degradation and ameliorates osteoarthritis development

SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling

Control of skeletal morphogenesis by the Hippo-YAP/TAZ pathway

Hippo/YAP1 promotes osteoporotic mice bone defect repair via the activating of Wnt signaling pathway

Suppression of YAP Ameliorates Cartilage Degeneration in Ankle Osteoarthritis via Modulation of the Wnt/β-Catenin Signaling Pathway

TEAD Mediates YAP-dependent Gene Induction and Growth Control

Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders

Angiomotin is a Novel Hippo Pathway Component That Inhibits YAP Oncoprotein.

Hippo-YAP/TAZ signaling in osteogenesis and macrophage polarization: Therapeutic implications in bone defect repair

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

YAP maintains cartilage stem/progenitor cell homeostasis in osteoarthritis

Up-regulation of FOXD1 by YAP Alleviates Senescence and Osteoarthritis.

Figure S1 to S13 from YAP is Essential for Treg-Mediated Suppression of Antitumor Immunity

Abnormal mechanical stress induced chondrocyte senescence by YAP loss-mediated METTL3 upregulation